Publications by authors named "Stuart Goldberg"

Claim this Profile
F
Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study - SIMPLICITY.
Michael J Mauro, Rüdiger Hehlmann, Loretta A Williams, Stuart L Goldberg, Mauricette Michallet

Leuk Lymphoma· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients.
Maram Almohaywi, Bruna M Sugita, Ariana Centa, Aline S Fonseca, Valquiria C Antunes, Stuart L Goldberg

Int J Mol Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bariatric surgery and oral chemotherapy: Where is the dosing guidance?
Stuart L Goldberg

Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML.
Geoffrey L Uy, Laura F Newell, Tara L Lin, Stuart L Goldberg, Matthew J Wieduwilt

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
Richard Tsai, John Hervey, Kathleen Hoffman, Jessica Wood, Jennifer Johnson, Stuart L Goldberg

JMIR Public Health Surveill· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial distribution and sources of nutrients at two coastal developments in South Kohala, Hawai'i.
Jazmine Panelo, Tracy N Wiegner, Steven L Colbert, Stuart Goldberg, Leilani M Abaya

Mar Pollut Bull· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
Hagop M Kantarjian, Kebede H Begna, Jessica K Altman, Stuart L Goldberg, Mikkael A Sekeres

Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19.
Donald A Berry, Andrew Ip, Brett E Lewis, Scott M Berry, Nicholas S Berry, Stuart L Goldberg

PLoS One· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Survival Impact of Self-Reported Symptom and Psychological Distress Among Patients With Multiple Myeloma.
Joshua Richter, Larysa Sanchez, Noa Biran, C K Wang, Kathryn Tanenbaum, Stuart L Goldberg

Clin Lymphoma Myeloma Leuk· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma.
Michele L Donato, Steven Park, Melissa Baker, Robert Korngold, Alison Morawski, Stuart Goldberg

JCI Insight· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.
Mark Stewart, Carla Rodriguez-Watson, Adem Albayrak, Julius Asubonteng, Andrew Belli, Stuart L Goldberg

PLoS One· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between Amplification (1q) and Prior Cancer in a Real-World De Novo Myeloma Cohort.
Elizabeth B Lamont, Andrew J Yee, Stuart L Goldberg, David S Siegel, Andrew D Norden

JNCI Cancer Spectr· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic-phase CML in clinical practice: 3-year European SIMPLICITY data.
Carlo Gambacorti-Passerini, Clara Chen, Catherine Davis, Ginny P Sen, Christy Guyan, Stuart L Goldberg

Eur J Haematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study.
Andrew Ip, Jaeil Ahn, Yizhao Zhou, Andre H Goy, Eric Hansen, Stuart L Goldberg

BMC Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study.
Noa Biran, Andrew Ip, Jaeil Ahn, Ronaldo C Go, Shuqi Wang, Stuart L Goldberg

Lancet Rheumatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients.
Sarah Goldman-Mazur, Artur Jurczyszyn, Jorge J Castillo, Anna Waszczuk-Gajda, Norbert Grząśko, Stuart L Goldberg

Leuk Lymphoma· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.
Andrew Ip, Donald A Berry, Eric Hansen, Andre H Goy, Andrew L Pecora, Stuart L Goldberg

PLoS One· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
Sarah Goldman-Mazur, Artur Jurczyszyn, Jorge J Castillo, Anna Waszczuk-Gajda, Norbert Grząśko, Stuart L Goldberg

Am J Hematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Smoldering Myeloma: Problems With Study Design as well as Biological and Clinical Implications.
Noa Biran, David H Vesole, Michele L Donato, Andrew Ip, Gurbakhash Kaur, Stuart Goldberg

J Clin Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia.
Jonathan E Kolitz, Stephen A Strickland, Jorge E Cortes, Donna Hogge, Jeffrey E Lancet, Stuart L Goldberg

Leuk Lymphoma· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker testing can direct care, but only if clinicians perform the right tests.
Stuart Goldberg, Allison Inserro

Am J Manag Care· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Profiling for , , , Microsatellite Instability, and Mismatch Repair Deficiency Among Patients With Metastatic Colon Cancer.
Martin E Gutierrez, Kristin S Price, Richard B Lanman, Rebecca J Nagy, Irfan Shah, Stuart L Goldberg

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists.
Donna M McNamara, Stuart L Goldberg, Lisa Latts, Deena M Atieh Graham, Stanley E Waintraub

Cancer Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis.
Jesus G Berdeja, Michael C Heinrich, Shaker R Dakhil, Stuart L Goldberg, Martha Wadleigh

Leuk Lymphoma· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial.
Guillermo Garcia-Manero, Antonio Almeida, Pierre Fenaux, Norbert Gattermann, Aristoteles Giagounidis, Stuart L Goldberg

Clin Lymphoma Myeloma Leuk· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis